FDA panel finds GE's imaging agent Datscan beneficial

08/11/2009 | Wall Street Journal, The

An FDA panel said GE Healthcare's Datscan, an imaging agent that helps identify neurological disorders, is safe to use in patients. Panel members said they would have preferred to have more information on whether the agent can pinpoint Parkinson's disease rather than only helping doctors localize it. The company plans to review data from patients who have used the product, an official said.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA